Modeling Immunity for Biodefense (U19)

The summary for the Modeling Immunity for Biodefense (U19) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Modeling Immunity for Biodefense (U19): This Funding Opportunity Announcement (FOA) solicits applications from single institutions, or consortia of institutions, to participate in a network of research groups developing computational models of immunity to infectious diseases other than HIV/AIDS. Applications are sought to develop, refine and validate computational models of immune responses (1) during or following infection, and/or (2) before and after vaccination against an infectious disease, through an iterative approach involving computational studies and immunological experimentation. The main goal of this FOA is to advance our understanding of the complex immune mechanisms triggered by infection and/or vaccination through the development and application of computational models of immunity, coupled with immunological experimentation to validate and improve the utility and robustness of the computational models.Another goal of this FOA is to make the computational models and data developed under this initiative readily available to the broader research community for further refinement or direct use in biological experimentation. This program will also support pilot projects, workshops, and symposia to foster the use of computational models of immunity by the broader research community.

Federal Grant Title:	Modeling Immunity for Biodefense (U19)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AI-14-028
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.855, 93.856
CFDA Descriptions:	Allergy, Immunology and Transplantation Research; Microbiology and Infectious Diseases Research
Current Application Deadline:	Jul 18, 2014
Original Application Deadline:	Jul 18, 2014
Posted Date:	Mar 21, 2014
Creation Date:	Mar 21, 2014
Archive Date:	Aug 18, 2014
Total Program Funding:	$6,000,000
Maximum Federal Grant Award:	$1,000,000
Minimum Federal Grant Award:	none
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Small businesses
Native American tribal governments (Federally recognized)
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Special district governments
Others (see text field entitled "Additional Information on Eligibility" for clarification)
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
County governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Private institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-14-028.html
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants: • Strategies for Eliminating HIV Proteins (R21 Clinical Trial Not Allowed); • Strategies for Eliminating HIV Proteins (R01 Clinical Trial Not Allowed); • Promoting Innovative Research in Treponema pallidum Pathogenesis (R21 Clinical Trial Not A...; • Novel Approaches for Radiation Biodosimetry and Medical Countermeasure Development (R21 Cl...; • Halting Tuberculosis (TB) Transmission (R01 Clinical Trial Optional); • Center for HIV/AIDS Vaccine Immunology (CHAVI); • Genomics of Transplantation Cooperative Research Program; • Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health: • Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed...; • Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional); • NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational R...; • Clinical and Translational Science Award (UM1 Clinical Trial Optional); • Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Pro...